Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
High myopia-sensorineural deafness syndrome is a rare genetic disease characterized by high myopia, typically ranging from -6.0 to -11.0 diopters, and moderate to profound, bilateral, progressive sensorineural hearing loss with prelingual-onset. Affected individuals do not present other systemic, ocular or connective tissue manifestations.
Features include always present findings: Inner ear hearing loss (sensorineural hearing impairment) and High myopia.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Ears | 1 | Inner ear hearing loss (sensorineural hearing impairment) |
SLITRK6 function has not been fully characterized.
High myopia-sensorineural deafness syndrome is caused by mutations in the SLITRK6 gene on chromosome 13.
Genetic testing for SLITRK6 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for high myopia-sensorineural deafness syndrome has been reported in the published literature.
Phenotype severity distribution: 2 always present features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for high myopia-sensorineural deafness syndrome.
131 publications have been identified in PubMed for high myopia-sensorineural deafness syndrome. Research spans Case Report / Case Series (34%), Basic Science / Preclinical (24%), and Epidemiology / Natural History (23%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 44 | 34% |
Data assembled from 7 of 12 sources · Last updated Sep 17, 2026, 11:32 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Laboratory research
32 |
24% |
Disease patterns and progression | 30 | 23% |
Research summaries | 11 | 8% |
Testing and diagnosis research | 6 | 5% |
Clinical study results | 4 | 3% |
New treatment approaches | 3 | 2% |
Other research | 1 | 1% |
Chentoufi FE (2026). [PMID: 40389825](https://pubmed.ncbi.nlm.nih.gov/40389825/). *J Biomol Struct Dyn*. [Basic Science / Preclinical]
Chen L (2026). [PMID: 41690513](https://pubmed.ncbi.nlm.nih.gov/41690513/). *Journal of genetics and genomics = Yi chuan xue bao*. [Review / Meta-Analysis]
Kutija Fučkar I (2026). [PMID: 42074586](https://pubmed.ncbi.nlm.nih.gov/42074586/). *Genes (Basel)*. [Epidemiology / Natural History]
Zou J (2026). [PMID: 41654259](https://pubmed.ncbi.nlm.nih.gov/41654259/). *Molecular & cellular proteomics : MCP*. [Basic Science / Preclinical]
Prasad S (2026). [PMID: 41955722](https://pubmed.ncbi.nlm.nih.gov/41955722/). *Sleep Med*. [Review / Meta-Analysis]
Li H (2026). [PMID: 41897284](https://pubmed.ncbi.nlm.nih.gov/41897284/). *Biomolecules*. [Basic Science / Preclinical]
Palacio JE (2026). [PMID: 41998697](https://pubmed.ncbi.nlm.nih.gov/41998697/). *Orphanet J Rare Dis*. [Epidemiology / Natural History]
Theunis M (2026). [PMID: 41126390](https://pubmed.ncbi.nlm.nih.gov/41126390/). *Ophthalmic genetics*. [Clinical Trial Publication]
Liu L (2026). [PMID: 42208963](https://pubmed.ncbi.nlm.nih.gov/42208963/). *Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi*. [Diagnostic / Biomarker]
Boespflug-Tanguy O (2026). [PMID: 42198847](https://pubmed.ncbi.nlm.nih.gov/42198847/). *Mol Ther*. [Gene Therapy / Novel Therapeutics]
AI-curated news mentioning high myopia-sensorineural deafness syndrome
Updated Mar 2, 2026
A new case series published on isolated infantile onset high myopia provides insights into long-term outcomes for affected patients. The study highlights the need for ongoing monitoring and potential interventions for this rare condition.
A recent study investigates the angle kappa in patients suffering from cataracts and high myopia, providing insights into the ocular parameters that may influence surgical outcomes. This research could inform future treatment strategies for these conditions.